THOR methylation as a pan-cancer mechanism of TERT activation: toward a clinically relevant epigenetic biomarker - Quiz - MDSpire

THOR methylation as a pan-cancer mechanism of TERT activation: toward a clinically relevant epigenetic biomarker

  • By

  • Alain Chebly

  • Edith Chevret

  • July 17, 2026

Share

Original Source(s)

THOR methylation as a pan-cancer mechanism of TERT activation: toward a clinically relevant epigenetic biomarker

  • by Alain Chebly, Edith Chevret

  • July 17, 2026

Related Content

Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates

Deep learning-based super-resolution dynamic contrast-enhanced radiomics model for predicting NSMP endometrial cancer

Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan